Dianthus Therapeutics (DNTH) Non-Current Assets (2017 - 2025)
Historic Non-Current Assets for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $163.6 million.
- Dianthus Therapeutics' Non-Current Assets rose 14509.05% to $163.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.8 million, marking a year-over-year increase of 43967.71%. This contributed to the annual value of $93.1 million for FY2024, which is 466479.02% up from last year.
- According to the latest figures from Q3 2025, Dianthus Therapeutics' Non-Current Assets is $163.6 million, which was up 14509.05% from $62.5 million recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' Non-Current Assets peaked at $163.6 million during Q3 2025, and registered a low of $1.0 million during Q3 2023.
- Its 4-year average for Non-Current Assets is $44.0 million, with a median of $33.1 million in 2022.
- In the last 5 years, Dianthus Therapeutics' Non-Current Assets plummeted by 9684.94% in 2023 and then soared by 651635.28% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Non-Current Assets (Quarter) stood at $1.1 million in 2022, then skyrocketed by 81.43% to $2.0 million in 2023, then skyrocketed by 4664.79% to $93.1 million in 2024, then skyrocketed by 75.74% to $163.6 million in 2025.
- Its last three reported values are $163.6 million in Q3 2025, $62.5 million for Q2 2025, and $77.6 million during Q1 2025.